ASTH Stock — Astrana Health, Inc.

Astrana Health, Inc. (ASTH)

Updated October 16, 2026.

ASTH is a Stock. Total return is 1115354.5% over the past 18.1 years, 1114616.9 points ahead of SPY at 737.6%.

Astrana Health is a healthcare management company that provides medical care services and care coordination across the United States through its Care Partners, Care Delivery, and Care Enablement segments, serving patients covered by Medicare, Medicaid, health maintenance organizations, and private insurance. The company does not currently have an established distribution schedule. This operating company may appeal to equity investors seeking healthcare sector exposure rather than income-focused investors.

ASTH performance versus SPY

Price and return data through 2026-10-16.

Total return is 1115354.5% over the past 18.1 years, 1114616.9 points ahead of SPY at 737.6%. Over the past year its total return — price change plus distributions reinvested — is 15.8%. Its deepest 1-year drawdown was 46.4%.

ASTH key facts

Asset type

Stock

Asset class

Equity

Inception date

09/08/2008

Distribution frequency

None

Last close

$36.81 (as of 2026-10-16)

Market cap

$1,825,936,712

Average volume

239989.0

Beta

1.033

Payout ratio

0.0%

P/E ratio

44.35

Forward P/E

8.9686

EPS

$0.83

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

ASTH risks and drawbacks

The deepest 1-year drawdown on record here is 46.4%.

Who may consider ASTH — and who may not

It is a weaker fit for investors who need monthly cash flow (ASTH does not currently distribute). This is educational context, not a recommendation to buy or sell.

More on ASTH

• All tickers starting with A

Tagged: Healthcare.

Frequently asked questions